Invasive brain‑computer interfaces represent the most promising technical pathway for high‑fidelity neuronal signal acquisition and the restoration of impaired neural functions.
On the evening of August 20, United Imaging Healthcare released its 2026 half‑year report. The company posted revenue of RMB 7.052 billion in the first half of the year, representing a 17.22% year‑on‑year increase. Its net profit attributable to parent shareholders stood at RMB 897 million, down 10.
Indian surgical‑robotics enterprise SS Innovations delivered an impressive growth performance in the first half of 2026.
DARPA is concurrently advancing two cutting‑edge technology pathways related to the brain.
Against the backdrop of the growing prevalence of minimally‑invasive diagnostic and therapeutic techniques in urology, the domestic localization of endoscopic devices has reached a critical inflection point.
Recently, the U.S. has launched a landmark collective research program on autonomous surgical robots.
On August 12, 2026, tricuspid‑valve interventional device developer Versa Vascular announced two major adjustments.
On August 10, Teledyne Technologies and Varex Imaging (hereinafter‑referred to as "Varex") jointly announced the signing of a definitive acquisition agreement.
According to recent official announcements from Gen‑pro Medical, its international expansion has reached a key milestone. The company’s multi‑port laparoscopic surgical robot has completed its first commercial installation and successfully performed the initial clinical operation at Penang Adventist
On August 10, 2026, foreign‑media reports stated that Shanghai Jieti Medical Technology Co., Ltd. is developing an intravascular‑implantable brain‑computer interface.
Philips has recently partnered with six companies to expand its capabilities in wearable devices and out‑of‑hospital patient monitoring.
According to the official update from Tuodao Medical recently, Tuoling®, its self‑developed laparoscopic surgical robot, has successfully completed multiple remote‑control clinical trials in urology, marking a momentous milestone in the development of domestic surgical robots.
On August 3, 2026, Andromeda Surgical, a developer of autonomous surgical robots for urology, announced the completion of its US$15‑million Series‑A financing round.
Shandong Aoxin Medical Technology Co., Ltd.’s core product, the 3.0T Extremity Joint Magnetic Resonance Imaging System, has successfully completed the update of its registration status. This confirms the latest official marketing authorization for this world-first specialized high-field MRI system a
On August 3, Shanghai Zhudong Technology Co., Ltd. announced the completion of its angel round financing, led by CAS Star. Co-investors include Legend Star, Ventech China, Daotong Investment, Inno Angel Fund, BGI Songhe Life Science Fund, Jifeng Capital and Jiadao Capital.
On July 28, Zhongke Xianjian co-hosted an IIT clinical investigator meeting on implantable cortical vision restoration brain-computer interfaces together with Shenzhen Eye Hospital, The Second People’s Hospital of Shenzhen, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, and
In January 2026, uSurg DoctorX, the thoracoabdominal endoscopic surgical system under United Imaging Healthcare, secured its first registration approval from the National Medical Products Administration (NMPA), obtaining official regulatory qualification for commercial launch.
Over the past two decades, the core thread of human-machine interaction has been enabling machines to better interpret human "commands".
On July 28, 2026, Dutch regenerative medicine firm Xeltis announced the completion of its latest financing round, raising USD 23.3 million (EUR 20.5 m
On July 27, 2026, Boston Scientific (NYSE: BSX) filed a Form 8-K with the U.S. Securities and Exchange Commission (SEC), disclosing that the company’s Board of Directors had approved the 2026 Global Restructuring Plan on July 21, 2026.
